Stock BAX BAXTER INTERNATIONAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Baxter International Inc.

Equities

BAX

US0718131099

Delayed Nyse
Other stock markets
 01:00:02 2024-07-03 pm EDT 		5-day change 1st Jan Change
33.16 USD +0.94% Intraday chart for Baxter International Inc. -2.18% -14.23%
Jul. 02 Cerus Corporation Appoints Dean Gregory to its Board of Directors CI
Jul. 02 Evercore ISI Adjusts Price Target on Baxter International to $45 From $46, Maintains Outperform Rating MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Cerus Corporation Appoints Dean Gregory to its Board of Directors
CI
Evercore ISI Adjusts Price Target on Baxter International to $45 From $46, Maintains Outperform Rating
MT
Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors
CI
Transcript : Baxter International Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM
Fitch Affirms and Withdraws Baxter's Ratings
AQ
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
BU
Transcript : Baxter International Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 09:30 AM
Ex-dividend day
FA
New Cohort Study Data Shows Baxter's Expanded Hemodialysis, Known as HDx Therapy is associated with approximately 25% Lower Mortality Rate for up to Four Years
AQ
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
BU
Baxter International Inc. Announces New Data Showing Expanded Hemodialysis, Known as HDX Therapy
CI
Baxter to Present at Jefferies 2024 Global Healthcare Conference
BU
Citigroup Adjusts Price Target on Baxter International to $38 From $44, Keeps Neutral Rating
MT
Transcript : Baxter International Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:00 PM
Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
BU
Baxter International's Clinolipid Injection Approved for Expanded Use in US
MT
Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
BU
Baxter International Inc. Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
CI
TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40
MT
Declaration of Voting Results by Baxter International Inc
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BAX Stock
  4. News Baxter International Inc.